Studies on human cytomegalovirus (CMV) have been limited by a paucity of molecular genetic techniques available for manipulating the viral genome. We have developed methods for site-specific insertion and deletion mutagenesis of CMV utilizing a modified Escherichia coli lacZ gene as a genetic marker. The lacZ gene was placed under the control of the major 13 gene regulatory signals and inserted into the viral genome by homologous recombination, disrupting one of two copies of this 13 gene within the L-component repeats of CMV DNA. We observed high-level expression of 13-galactosidase by the recombinant in a temporally authentic manner, with levels of this enzyme approaching 1% of total protein in infected cells. Thus, CMV is an efficient vector for high-level expression of foreign gene products in human cells. Using back selection of lacZ-deficient virus in the presence of the chromogenic substrate 5-bromo-4-chloro-3-indolyl fJ-D-galactoside, we generated random endpoint deletion mutants. Analysis of these mutants revealed that CMV DNA sequences flanking the insert had been removed, thereby establishing this approach as a means of determining whether sequences flanking a lacZ insertion are dispensable for viral growth. In an initial test of the methods, we have shown that 7800 base pairs of one copy of L-component repeat sequences can be deleted without affecting viral growth in human fibroblasts.
ABSTRACT
Studies on human cytomegalovirus (CMV) have been limited by a paucity of molecular genetic techniques available for manipulating the viral genome. We have developed methods for site-specific insertion and deletion mutagenesis of CMV utilizing a modified Escherichia coli lacZ gene as a genetic marker. The lacZ gene was placed under the control of the major 13 gene regulatory signals and inserted into the viral genome by homologous recombination, disrupting one of two copies of this 13 gene within the L-component repeats of CMV DNA. We observed high-level expression of 13-galacto- sidase by the recombinant in a temporally authentic manner, with levels of this enzyme approaching 1% of total protein in infected cells. Thus, CMV is an efficient vector for high-level expression of foreign gene products in human cells. Using back selection of lacZ-deficient virus in the presence of the chromogenic substrate 5-bromo-4-chloro-3-indolyl fJ-D-galactoside, we generated random endpoint deletion mutants. Analysis of these mutants revealed that CMV DNA sequences flanking the insert had been removed, thereby establishing this approach as a means of determining whether sequences flanking a lacZ insertion are dispensable for viral growth. In an initial test of the methods, we have shown that 7800 base pairs of one copy of L-component repeat sequences can be deleted without affecting viral growth in human fibroblasts.
Human cytomegalovirus (CMV), a herpesvirus, infects a majority of the population and causes severe disease in newborns and immunocompromised individuals (1) . CMV has the largest DNA genome of any human virus [240 kilobase pairs (kbp)], with a coding capacity for at least 100 proteins expressed in at least three kinetic classes (2) . The viral genome exists as one of four sequence isomers generated by the inversion of the L and S components, which are bounded by inverted repeats (ab and ca sequences; see Fig.  1 ). The earliest set of genes, the a or immediate early genes, are controlled by promoter-proximal transcriptional regulatory elements that are responsive to a virion transactivating factor (8, 9) . In contrast, (3 (early) and y (late) genes are regulated by a combination of transcriptional and posttranscriptional signals (2, (10) (11) (12) . The most extensively studied (3 gene encodes a 2.7-kilobase (kb) RNA that is the most abundant steady-state polyadenylylated transcript made during infection (6, 7) and is present in two copies in the CMV (Towne) genome, one copy in each of the b repeat sequences of the L component (2) . Transcriptional (8) as well as posttranscriptional (11) regulatory signals have been shown previously to play a role in the temporal expression of this gene by using transient assays that relied on the Escherichia coli lacZ gene as an indicator of gene expression.
Analysis of regulatory signals involved in CMV gene expression has been limited to the use of transient assays because methods have not been available to engineer mutations into the viral genome. The introduction of site-specific mutations into herpes simplex virus (HSV) and vaccinia virus has proved to be invaluable to understanding the functional organization of their genomes (13) (14) (15) . Genetic manipulation of these viruses has relied upon the use of the thymidine kinase gene as a genetic marker to generate insertion and deletion mutants (14) , a strategy that cannot readily be used with CMV given a host range limited to human fibroblasts in cell culture. We adapted the E. coli lacZ gene, previously used as a dominant genetic marker in many systems including both insect and animal viruses (16, 17) , and developed a simple procedure for both insertion and deletion mutagenesis. The lacZ gene was introduced into the viral genome under the control of CMV gene expression signals derived from the major 3 gene, resulting in the regulated expression of lacZ as a /3 gene and allowing 3-galactosidase to accumulate to levels approaching 1% of total cell protein. Besides demonstrating the high-level expression of a foreign gene by CMV, our work shows that lacZ can be used to generate random endpoint deletion mutations spanning the insertion site, a method that we apply to the b sequence repeats of CMV (Towne). This approach overcomes the limitations that have impeded genetic analysis of CMV and opens the way for systematic mutagenesis of the viral genome.
MATERIALS AND METHODS
Cells, Virus, Viral DNA, and Viral Gene Expression. The cultivation of human fibroblast (HF) cells, growth of CMV, preparation of viral DNA, and Southern blot hybridization have been described (3, 8) . Preparation of RNA and RNA blot hybridization as well as protein radiolabeling, sample preparation, NaDodSO4/7.25% PAGE, immunoblot analysis, and autoradiography have been described (10, 11) .
Plasmid Construction. The plasmid pON256 was prepared by inserting a 5.9-kbp EcoRI partial digest fragment from pON241 (8), containing the major (-gene promoter/regulatory/5' leader sequences fused to lacZ protein-coding and SV40 polyadenylylation and origin/enhancer sequences, into the unique EcoRI site of pON227, a pBR322-based plasmid containing a 1.6-kbp EcoRI/BamHI fragment of the p-gene 3' flanking sequences. Approximately 470 base pairs (bp) of sequences internal to the 2.7-kb transcript were deleted in the process of making pON256. Construction of pON 1, pON208, and pON258 has been described (3, 8, 11 The a sequence is a terminal direct repeat with an inverted copy (a') at the L/S junction (3). A complete HindII1 map (above line I; refs. 4 and 5) and Cla I terminal fragments (below line I, designated T1, T2, T3, and T4) are indicated. T2 and T4 are shown in parentheses because they together constitute the J3 CIa I L/S junction fragment in the prototype genome arrangement shown here but become termini in other genome arrangements. Line II shows the expanded region (delineated with broken lines) containing the HindII1 K (9.7 kbp) and 0 (7.8 kbp) fragments. Direction of the 2.7-kb CMV /8 transcript (6, 7), which is encoded by the two b sequence repeats in the CMV genome, is shown by a dotted arrow below line II. DNA probes used in Southern blot analysis of RC256 DNA are shown above line II. The a sequence is indicated by a white box at the end of the HindIII K fragment. Line III shows the plasmid pON256 constructed as described in Materials and Methods. The lacZ/simian virus 40 (SV40)-specific probe carried in pON1 (8) glycerol shock (3). The total progeny virus from the cotransfection was harvested, serially diluted, and plated onto fresh HF cells. Six days after infection, viral plaques were overlaid with Dulbecco's modified minimal essential medium (GIBCO) containing 150 Ag of X-Gal (Sigma) per ml, 0.5% agarose (Bethesda Research Laboratories), and 10% (vol/vol) NuSerum (Collaborative Research, Waltham, MA). Prospective recombinant virus was identified by the appearance of blue plaques 6-24 hr after overlay. Blue plaques were picked, sonicated, serially diluted, and passaged onto fresh HF cells a total of three times. To isolate viruses with deletions, RC256 was diluted and plated onto HF cells, which were subsequently maintained for 9 days in medium with 0.1% pooled human gamma globulin (Cutter) to prevent secondary spread of virus. Nine days after infection, the antibody-containing medium was washed out of cultures and they were overlaid with X-Gal-containing medium as described above. High-titered virus stocks were made, and viral DNA was prepared for Southern blot analysis (3). RESULTS Construction of RC256. To place lacZ under the control of strong CMV gene expression signals and to provide flanking sequences to target its insertion into a region of the CMV genome, we constructed pON256 (Fig. 1) . We used a 800-bp fragment containing the 5' flanking sequence upstream of the transcription start site and 142 bp of transcribed 5' leader sequence from the major 13 gene (8) , which normally directs the expression of the most abundant transcript made during CMV infection (2, 6, 7) . It has been shown previously (8, 11) that this fragment contains transcriptional as well as posttranscriptional regulatory signals derived from the 83 gene. This ,3-gene promoter/regulator/5' leader was fused to a 4.8-kbp DNA fragment containing lacZ sequences and SV40 transcription termination signals (8) and then was flanked 3' with 1.6 kbp of /3-gene sequence as shown in Fig. 1A . The CMV sequences flanking the insert were used to target recombination of lacZ into one copy of the major /3 gene in the viral genome by using cotransfection of intact CMV (Towne) DNA and linearized pON256 (Fig. 1A) . Recombinant virus was initially identified by the appearance of blue plaques (Fig. 1B) on infected HF monolayers within 6-24 hr after the infected cells were overlaid with the chromogenic /3-galactosidase substrate, X-Gal. 83-Galactosidase-expressing recombinants constituted 10% of the cotransfection progeny, as indicated by the number of blue plaques relative to total plaques.
We used Southern blot hybridization to establish that IacZ was targeted to the appropriate region in the CMV genome, disrupting the /3 gene (Fig. 2) . Our analysis revealed that the lacZ gene was precisely inserted within the major /8 gene within one copy of the b repeat sequence of the L component. A deletion of 5.5 kbp occurred adjacent to the insertion site, presumably because of packaging limits of the virion. As expected for an insertion within the b sequence,,inversion of the L and S components of the CMV genome (2, 3) resulted in three HindIII fragments affected by the insertion in the recombinant. One L terminal (T*) and two L/S junction (J*) HindIII fragments hybridized to the lacZ probe (pON1) (Fig.  2) . One copy ofthe CMV (Towne) HindIII K fragment, which contains the b repeat sequence, was disrupted by the insertion, while one remained unaffected. Cla I did not cut within the b sequences of CMV (Towne) DNA (3), and, although it does cut twice within the lacZ gene (Fig. 1A) , it was the best available enzyme to establish the structure of RC256 unam- biguously. Because of genome inversion, Cla I digestion of parental CMV (Towne) DNA resulted in four separate terminal fragments (7.6 kbp, T1; 13 kbp, T2; 15 kbp, T3; and 26 kbp, T4) and four separate junction fragments (20.6 kbp, JI; 22.6 kbp, J2; 39 kbp, J3; and 41 kbp, J4). As a result of inversion, RC256 had one T* and two J* Cla I fragments identified by hybridization using the pON1 probe (Fig. 2 ). An a-sequence-specific probe, pON208 (Fig. 1A) , as expected (3) hybridized to the four junction (J1-J4) and four terminal (T1-T4) Cla I fragments in CMV (Towne) DNA digests. In RC256 DNA, T3, J2, and J4 were missing and replaced with new junction and terminal fragments (Fig. 2) . A 315-bp probe representing sequences internal to the major 8 gene but absent from pON256 was used to confirm the loss of the T3, J2, and J4 Cla I fragments from the RC256 genome (Fig. 2) . Cla I restriction digests were also hybridized with a probe for 5' flanking sequences, pON258; a 4.8-kbp fragment was detected, representing a deletion of 5.5 kbp of sequences upstream of the 8 gene (Fig. 2) . The deletion was entirely within the b sequence repeats and was revealed by the absence of HindIII 0 fragment in DNA restriction patterns and the presence of a new Hind1II fragment of 6.7 kbp within RC256 DNA (indicated by "A' in Fig. 2) . Furthermore, Xba I 0, BamHI G, and EcoRI 0 fragments, expected to be present in DNA digests, were absent (data not shown). The size and position ofthe deletion were established by Southern blot analyses using additional digests and probes as described in the legend to Fig. 2 . These analyses indicate that the 3' end ofthe deletion lies > 175 bp upstream ofthe transcription start site, suggesting that sufficient 5' proximal sequences remained to regulate expression of j3-galactosidase. DNA fragments could be detected in long exposures of the autoradiograms (data not shown) that were consistent with a proportion (5%) of the viral genomes in this stock lacking the 5.5-kbp deletion adjacent to the lacZ insert, possibly involving a process ofgene conversion previously observed in other herpesvirus repeats (19, 20) . Expression offi-Galactosidase by RC256. The transcriptional activity of RC256 was examined by RNA blot analysis of total cellular RNA prepared 24 hr after infection. A 4.7-kb transcript with homology to lacZ sequences was detected (Fig. 3A) . The size of this transcript was identical to previous observations with a related construct [pON241, studied by using transient assays on HF cells (11) ] and indicated that transcription termination occurred downstream of the expected site in SV40 sequences (21) . In addition, the second, unaltered copy of the 8 gene expressed a wild-type 2.7-kb transcript (data not shown) as expected from the Southern blot analysis of RC256 genome structure (Fig. 1) .
High levels off-galactosidase expression were observed in RC256-infected cells. Cells were infected with the wild-type or recombinant virus and then radiolabeled 72 hr later with 200 ACi of [35S]methionine per ml. Proteins were analyzed by NaDodSO4/PAGE, transferred to nitrocellulose filters, and autoradiographed (Fig. 3B) separating proteins by NaDodSO4/PAGE. Autoradiograpbic data (Fig. 3C) indicated that B-galactosidase synthesis beg-"a 6-8 hr after infection and reached maximal rates 1O-;12 . :
. . . . 5 gig) prepared from cells infected with CMV (Towne) or RC256 was subjected to hybridization analysis using the 32P-labeled lacZ probe pON1, followed by autoradiography as previously described (11) . (B) NaDodSO4/PAGE analysis of f8-galactosidase expression. Infected cells were radiolabeled for 2 hr with 200 ACi of [35S]methionine per ml 72 hr after infection (1 Ci = 37 GBq), solubilized in the presence of 2-mercaptoethanol and NaDodSO4, separated by NaDodSO4/PAGE (7.5% gel), transferred to nitrocellulose, and autoradiographed as described (10) . The identity of infected cell proteins (ICPs) ICP4, the major capsid protein (150 kDa); ICP27, the matrix protein (68 kDa); and ICP36, the major DNA binding protein (52 kDa) are indicated. (C) Kinetics of 8-galactosidase expression in RC256-infected cells. RC256-infected cells were radiolabeled for 2 hr at 2, 6, 10, 24, and 48 hr after infection or after cycloheximide (50 ,ug/ml, Calbiochem) block from 1 hr before to 2 or 6 hr after infection. Cell lysates were prepared and subjected to NaDodSO4/PAGE, followed by autoradiography to analyze separated proteins. after infection. As expected from the temporal class of the natural major gene (2, 6, 7) and previously published transient assays (8, 11 ) that established the P-gene kinetic class of this promoter/regulator/5' leader, cycloheximide treatment blocked detectable P-galactosidase expression from RC256 (Fig. 3C) .
Deletion Mutants. The insertion of the lacZ gene into CMV showed that this gene could be used as a dominant genetic marker in a herpesvirus. To increase the utility of lacZ as a genetic marker in CMV, we investigated its use to generate random endpoint deletions flanking the insertion site by back selection of RC256 to the p-galactosidase-deficient phenotype. Putative deletion mutants were identified as white (nonstained) plaques after infected cells were overlaid with X-Gal-containing medium and appeared with a frequency of =10% of total plaques. These lacZ-deficient viruses were plaque-purified, DNA was prepared, and the genome structure of one mutant whose deletion endpoints extended outside of lacZ sequences was analyzed in detail by Southern blot hybridization (Fig. 4) . The revertant (RCA256-1) had lost all IacZ homologous sequences as evidenced by their complete absence (with the pON1 probe) in viral DNA (Fig. 4) . Cla I fragments of RCA&256-1 DNA probed with the 5' flanking sequence probe, pON258 (Fig. 1A) the transcriptional and posttranscriptional regulation of CMV genes can now be studied in the context of the viral genome, a process that will establish the physiological relevance of these signals. The kinetics of regulation of 3-galactosidase expression by the 83-gene promoter/regulator/5' leader used here are consistent with data obtained with our previous transient assays (8) . Further work using constructs that remove portions of the 5' leader will establish the physiological contribution of posttranscriptional regulatory elements previously mapped (11 trials, and appears to be unable to infect humans latently (24) (25) (26) . Recombinant CMV (Towne) engineered to express T3A new proteins by the techniques described here may provide an alternative strategy to the development of new human vaccines.
